At Centro de Biotecnología y Biomedicina SpA, we are committed to advancing biotechnology and biomedicine through research, development, and innovation. Our multidisciplinary team uses cutting-edge technologies to create solutions that improve human and animal health while promoting sustainable practices. We operate an animal research unit dedicated to conducting preclinical studies and validating bioproducts in large-animal models, including rabbits, sheep, pigs, chickens, turkeys, and cattle. We provide specialized preclinical, toxicological, and efficacy assessment services for pharmaceutical products and a wide range of biotechnological applications. We collaborate with academic institutions, companies, and other strategic partners at both the national and international levels to combine complementary capabilities and foster a dynamic environment for scientific research, technological validation, and technology transfer. Through these partnerships, we seek to accelerate the development of innovative bioproducts and generate a meaningful impact on health, animal production, and the environment.
Next-generation therapeutics and modalities
Innovative cancer treatment modalitiesmRNA-based vaccinesMicrobiome-based therapies and diagnosticsExosome-based therapies and delivery systemsInnovative antibiotics (new mechanisms of action, antimicrobial peptides, phage therapy, and alternatives to traditional antibiotics)
Agricultural and veterinary innovations
Development of new vet therapies
Representatives
Director of R&D&I in Cancer Research and Biopharmaceuticals
We seek international project cooperation in biopharmaceutical and veterinary product development and formulation. We also offer CRO services for efficacy, safety, toxicology, validation, and preclinical studies in large-animal models.
Expertise offered
Completing the consortia
Project idea is seeking partners
Agricultural and veterinary innovations
Advanced diagnostics and data technologies
Next-generation therapeutics and modalities
Author
Director of R&D&I in Cancer Research and Biopharmaceuticals at Centro de Biotecnología y Biomedicina SpA